BRPI0412636A - imidazopirimidinas substituìdas para a prevenção e tratamento de cáncer - Google Patents
imidazopirimidinas substituìdas para a prevenção e tratamento de cáncerInfo
- Publication number
- BRPI0412636A BRPI0412636A BRPI0412636-0A BRPI0412636A BRPI0412636A BR PI0412636 A BRPI0412636 A BR PI0412636A BR PI0412636 A BRPI0412636 A BR PI0412636A BR PI0412636 A BRPI0412636 A BR PI0412636A
- Authority
- BR
- Brazil
- Prior art keywords
- sub
- treatment
- cancer prevention
- substituted imidazopyrimidines
- imidazopyrimidines
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 150000005237 imidazopyrimidines Chemical class 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- 230000002113 chemopreventative effect Effects 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 150000003463 sulfur Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200301906 | 2003-07-30 | ||
| PCT/EP2004/008476 WO2005014598A1 (en) | 2003-07-30 | 2004-07-29 | Substituted imidazopyrimidines for the prevention and treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0412636A true BRPI0412636A (pt) | 2006-09-26 |
Family
ID=34130555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0412636-0A BRPI0412636A (pt) | 2003-07-30 | 2004-07-29 | imidazopirimidinas substituìdas para a prevenção e tratamento de cáncer |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060189631A1 (enExample) |
| EP (1) | EP1660500B1 (enExample) |
| JP (1) | JP2007500160A (enExample) |
| KR (1) | KR20060034303A (enExample) |
| CN (1) | CN1860121A (enExample) |
| AT (1) | ATE380816T1 (enExample) |
| AU (1) | AU2004263297A1 (enExample) |
| BR (1) | BRPI0412636A (enExample) |
| CA (1) | CA2534292A1 (enExample) |
| DE (1) | DE602004010680T2 (enExample) |
| EA (1) | EA009038B1 (enExample) |
| ES (1) | ES2298798T3 (enExample) |
| WO (1) | WO2005014598A1 (enExample) |
| ZA (1) | ZA200601706B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007096764A2 (en) * | 2006-02-27 | 2007-08-30 | Glenmark Pharmaceuticals S.A. | Bicyclic heteroaryl derivatives as cannabinoid receptor modulators |
| TW200817410A (en) | 2006-08-07 | 2008-04-16 | Incyte Corp | Triazolotriazines as kinase inhibitors |
| EP2497470B8 (en) | 2006-11-22 | 2015-12-02 | Incyte Holdings Corporation | Imidazotriazines and imidazopyrimidines as kinase inhibitors |
| PA8793301A1 (es) | 2007-08-14 | 2009-04-23 | Bayer Schering Pharma Ag | Imidazoles bicíclicos fusionados |
| EP2062893A1 (en) * | 2007-10-18 | 2009-05-27 | Bayer Schering Pharma AG | Fused imidazoles for cancer treatment |
| NZ589622A (en) | 2008-05-21 | 2012-10-26 | Incyte Corp | Salts of 2-fluoro-N-methyl-4-[7-(quinolin-6-yl-methyl)-imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same |
| NZ599289A (en) | 2009-10-16 | 2014-11-28 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| KR101870878B1 (ko) | 2010-02-03 | 2018-06-25 | 인사이트 홀딩스 코포레이션 | Ｃ―ＭＥＴ 억제제로서의 이미다조〔１，２―ｂ〕〔１，２，４〕트리아진 |
| US8410117B2 (en) * | 2010-03-26 | 2013-04-02 | Hoffmann-La Roche Inc. | Imidazopyrimidine derivatives |
| AU2012238589B2 (en) | 2011-04-07 | 2017-02-16 | Bayer Intellectual Property Gmbh | Imidazopyridazines as Akt kinase inhibitors |
| CN102796103A (zh) * | 2011-05-23 | 2012-11-28 | 南京英派药业有限公司 | 6-（芳基甲酰）咪唑并[1,2-a]嘧啶和6-（芳基甲酰）[1,2,4]三唑并[4,3-a]嘧啶作为Hedgehog抑制剂及其应用 |
| US9186361B2 (en) | 2013-03-15 | 2015-11-17 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| UY35400A (es) * | 2013-03-15 | 2014-10-31 | Novartis Ag | Compuestos y composiciones para el tratamiento de enfermedades parasitarias |
| US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| WO2014151630A2 (en) | 2013-03-15 | 2014-09-25 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
| PE20160865A1 (es) | 2013-12-19 | 2016-09-03 | Novartis Ag | Derivados de [1,2,4] triazolo [1,5-a]pirimidina como inhibidores de proteasoma para el tratamiento de enfermedades parasitarias tales como leishmaniasis |
| JP2018507881A (ja) | 2015-03-11 | 2018-03-22 | メリンタ セラピューティクス，インコーポレイテッド | 抗微生物化合物ならびにこれらを作製および使用する方法 |
| CA3023317A1 (en) | 2016-05-06 | 2017-11-09 | Melinta Therapeutics, Inc. | Antimicrobials and methods of making and using same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3455924A (en) * | 1967-02-08 | 1969-07-15 | Upjohn Co | Dianisylimidazoles |
| US5700826A (en) * | 1995-06-07 | 1997-12-23 | Ontogen Corporation | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance |
| ES2140354B1 (es) * | 1998-08-03 | 2000-11-01 | S A L V A T Lab Sa | Imidazo (1,2a) azinas sustituidas como inhibidores selectivos de la cox-2. |
-
2004
- 2004-07-29 KR KR1020067001923A patent/KR20060034303A/ko not_active Withdrawn
- 2004-07-29 BR BRPI0412636-0A patent/BRPI0412636A/pt not_active IP Right Cessation
- 2004-07-29 CA CA002534292A patent/CA2534292A1/en not_active Abandoned
- 2004-07-29 EP EP04763583A patent/EP1660500B1/en not_active Expired - Lifetime
- 2004-07-29 DE DE602004010680T patent/DE602004010680T2/de not_active Expired - Fee Related
- 2004-07-29 JP JP2006521521A patent/JP2007500160A/ja not_active Withdrawn
- 2004-07-29 ZA ZA200601706A patent/ZA200601706B/en unknown
- 2004-07-29 AT AT04763583T patent/ATE380816T1/de not_active IP Right Cessation
- 2004-07-29 CN CNA2004800279669A patent/CN1860121A/zh active Pending
- 2004-07-29 AU AU2004263297A patent/AU2004263297A1/en not_active Abandoned
- 2004-07-29 EA EA200600330A patent/EA009038B1/ru not_active IP Right Cessation
- 2004-07-29 ES ES04763583T patent/ES2298798T3/es not_active Expired - Lifetime
- 2004-07-29 WO PCT/EP2004/008476 patent/WO2005014598A1/en not_active Ceased
-
2006
- 2006-01-27 US US11/340,856 patent/US20060189631A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004263297A1 (en) | 2005-02-17 |
| CA2534292A1 (en) | 2005-02-17 |
| JP2007500160A (ja) | 2007-01-11 |
| ATE380816T1 (de) | 2007-12-15 |
| DE602004010680D1 (de) | 2008-01-24 |
| DE602004010680T2 (de) | 2009-01-02 |
| EA009038B1 (ru) | 2007-10-26 |
| EP1660500B1 (en) | 2007-12-12 |
| ZA200601706B (en) | 2007-09-26 |
| KR20060034303A (ko) | 2006-04-21 |
| CN1860121A (zh) | 2006-11-08 |
| EA200600330A1 (ru) | 2006-08-25 |
| US20060189631A1 (en) | 2006-08-24 |
| ES2298798T3 (es) | 2008-05-16 |
| EP1660500A1 (en) | 2006-05-31 |
| WO2005014598A1 (en) | 2005-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0412636A (pt) | imidazopirimidinas substituìdas para a prevenção e tratamento de cáncer | |
| DK0931788T3 (da) | Metalloproteasehæmmere | |
| HRP20090281T1 (hr) | 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti | |
| SE0303180D0 (sv) | Novel compounds | |
| PL373645A1 (en) | Pyrrolidinedione substituted piperidine-phthalazones as pde4 inhibitors | |
| DK1487444T3 (da) | Anvendelse af pyridylamider som angiogeneseinhibitorer | |
| BR0314688A (pt) | Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina | |
| ATE440603T1 (de) | 8-hydroxychinolinderivate | |
| DE60107449D1 (de) | Substituierte aminopropoxyarylderivate als lxr agonisten | |
| EA200301216A1 (ru) | Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания | |
| UA87153C2 (ru) | Энантиомерно чистые аминогетероарильные соединения как ингибиторы протеинкиназы | |
| NO20061793L (no) | 1,4-disubstituerte isoquinilonderlvater som RAF-kinaseinhibitorer nyttige for behandling av proliferative sykdommer | |
| EA200300829A1 (ru) | Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6 | |
| DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
| CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
| NO20063275L (no) | Anvendelse av substituerte 2-aminotetraliner for forebyggende behandling av Parkinsons sykdom | |
| ATE374190T1 (de) | Tetrahydrochinazolinderivate als cfr-antagonisten | |
| TW200730494A (en) | Novel compounds | |
| ATE498600T1 (de) | Inden derivate als pharmazeutika | |
| HRP20080057T3 (en) | 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof | |
| SE0103710D0 (sv) | Compounds | |
| ATE492534T1 (de) | 1h-indol-5-ylpiperazin-1-ylmethanonderivate | |
| ATE453389T1 (de) | Bestimmte pharmazeutisch wertvolle substituierte aminoalkyl-heterocyclen | |
| BRPI0415390A (pt) | compostos de pirazinona substituìda para o tratamento da inflamação | |
| ATE419242T1 (de) | Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |